Time for a Scorecard📊and thesis📑updates for purchases done in Feb/Mar 2020. Last review done in late April. How far things have come since then.😯

Not taking any drastic actions, other than few sells in fully valued, slower growth Co.'s.

Events since then
✔️Co's reporting two Qtrly reports
✔️Accelerating growth for few sectors
✔️Understandable problems for few others
✔️Crazy run-ups & valuations in the last 9 mo's, supported by biz growth in some cases, but mostly due to Monetary factors & Investor enthusiasm...
I usually buy for two scenarios

1⃣Leading Co's within strong secular trends, that also have strong Management Teams and solid Financials (Rev growth, Profitability or improving Margins/FCF prospects, no balance sheet risk...).
These are bought with the intention of holding for the long-term as long as the thesis is intact or getting better. Strongly intend to add along the way. Ex : $ROKU $PINS $TWLO $DOCU $W $NOW $WDAY $NVCR $MTCH in the above table.
2⃣More mature and stable Co.'s but with some growth left (no Financial risk), mainly bought for their current under-valuation, with the intent to sell when the Market or those stocks recover. Ex : $BIP $BUD $VTR $BR $BA in above table.
Occasional unplanned sells like
- $W one lot in late May, as the stock 8X'ed in 2 months after bottoming in March.
- $UBER after 3X (but unfortunately, just before the Vaccine news started coming out) as I was more interested in under-valuation in March, than for long-term.
I'm guilty of usually squeezing bulk of my buys in high Volatility periods.

Few purchases made after this (not recommendations)
$CRM (Dec, $220)
$ZM (Dec, $380)
$DOCU (Nov, $201)
$ETSY (Nov, $120)
$TDOC (Nov, $197)
$MDB (Sep, $209)
$FSLY (Sep, $76)
Updating my favorite investing concept & illustration for high volatility periods.

When good Co.'s are heavily discounted and put for you on a platter, given that you have a Watchlist &
✔️done your research
✔️developed thesis/conviction
✔️not worried about further downside
Every one needs their own toolkit for high volatility periods and bear markets. This is what will
✔️ensure you won't let fear drastically change your long-term plans and strategy
✔️get you thru to the other side
✔️maybe even take advantage of the low prices
Here are few concepts that have helped me in the past high volatility periods.

✔️Ben Graham's Mr Market: He's mostly pretty smart/stable but high VIX (fear/uncertainty) & extremely low VIX (complacency) are when you need to be little contrarian & take advantage of his behavior.
✔️"You make a lot of money (by investing in good Co's) during Bear Markets, You just don't realize it at the time" - Shelby Davis.

✔️When the price of a Stock (in a good Company) falls a lot, it actually becomes less risky (Howard Marks)
✔️Hyperbolic discounting : Fear causing time horizons to shrink, and Market valuing good Co's with bright future prospects as if they're mature/declining businesses. h/t @IntrinsicInv

✔️Cash and Courage during a crash are invaluable (Buffett).
Anyway, this is just a random collection of thoughts about high volatility periods (like March), some results/updates, and some concepts that help during those periods.

/END. 👍

More from Ram Bhupatiraju

More from Economy

You May Also Like

https://t.co/6cRR2B3jBE
Viruses and other pathogens are often studied as stand-alone entities, despite that, in nature, they mostly live in multispecies associations called biofilms—both externally and within the host.

https://t.co/FBfXhUrH5d


Microorganisms in biofilms are enclosed by an extracellular matrix that confers protection and improves survival. Previous studies have shown that viruses can secondarily colonize preexisting biofilms, and viral biofilms have also been described.


...we raise the perspective that CoVs can persistently infect bats due to their association with biofilm structures. This phenomenon potentially provides an optimal environment for nonpathogenic & well-adapted viruses to interact with the host, as well as for viral recombination.


Biofilms can also enhance virion viability in extracellular environments, such as on fomites and in aquatic sediments, allowing viral persistence and dissemination.